Bruce Moore, former vice president of marketing for the Diasonicsultrasound division, was named president of the division lastmonth. He was previously vice president of marketing for DiasonicsMRI. Moore returned to Diasonics--along with president and
Bruce Moore, former vice president of marketing for the Diasonicsultrasound division, was named president of the division lastmonth. He was previously vice president of marketing for DiasonicsMRI.
Moore returned to Diasonics--along with president and COO RoderickA. Young--following Toshiba's acquisition of the magnetic resonanceimaging business (SCAN 8/1/90). Young had initially taken on directresponsibility for the Diasonics ultrasound business.
A replacement for Moore as vice president of marketing forthe ultrasound division assumed his new responsibilities thisweek. William E. Richardson was formerly general manager of theinformation systems division of ADAC Laboratories.
While Diasonics improved the profitability of its businessessince the sale of the MRI division, ultrasound continued to lagbehind expectations last year (SCAN 2/13/91). Sales of the vendor'sSpectra high-end radiology ultrasound scanner should pick up nowthat a new color-flow Doppler architecture has been fully implemented,Moore said.
The vendor introduced its Spectra Plus color architecture atthe 1990 Radiological Society of North America meeting but didnot finish software revisions and begin demonstrating the packagein the field until last month, he said.
Diasonics' international ultrasound sales, through its Swisssubsidiary Sonotron, were strong last year despite the fact thatSpectra sales had not yet kicked in. Sonotron is expected to launcha Spectra product tailored to Europe this year.
Ultrasound sales should also get a boost from the incorporationof Diasonics' intravascular ultrasound system (IVUS) as an optionon Spectra. IVUS had been sold previously only as a stand-alonedevice. The IVUS option on Spectra will cost about $40,000, orless than half of what the stand-alone unit costs, Moore said.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.